A comprehensive view of Hospital / Clinical Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Logistic & Supply Chain Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Oncology drugs market expected to reach US$332.4B by 2033, driven by increasing global cancer rates and advancements in cancer treatments; the market is forecast to grow at a CAGR of 6.7% from 2024 to 2033: Marketresearch.biz

Health Canada approves Remsima SC from Celltrion Healthcare Canada for maintenance therapy in adults with active ulcerative colitis and Crohns disease; the drug was initially approved in 2021 for rheumatoid arthritis treatment

Eli Lilly plans to launch revolutionary weight-loss drug tirzepatide in India by 2025, aiming to tackle the country's obesity crisis; CEO David Ricks advocates for policy enhancements to attract greater investment

Becker's Hospital Review presents comparative analysis of GLP-1 drugs, AI, and corporate layoffs; cybersecurity incident affects Change Healthcare operations, and Mark Cuban's drug company and CMS citation trends discussed

CHMP recommends approval of Bristol Myers' Reblozyl for adult patients with transfusion-dependent anemia due to myelodysplastic syndromes; if approved by the European Commission, it would represent the fourth authorized indication for Reblozyl in the EU

Ask us about our Logistic & Supply Chain market view

Trending Chart

Interactive chart with headline count